BPA Call VA25917A0058-36C25918N3791

This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The $10,157.40 contract is for the provision of Myriad's Prolaris quantitative PCR testing services to assess prostate cancer tumor aggressiveness and guide treatment approaches. No set-aside designation was mentioned. Myriad Genetics, a...

This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...

The federal contract award HHSN269201600343P was issued by the National Institutes of Health (NIH) Clinical Center to Preventiongenetics LLC, a for-profit limited liability company that specializes in genetic testing services. The $8,000 firm fixed-price purchase order is for specialized genetic testing and analysis to support ongoing research studies at the NIH Clinical Center. Preventiongenetics LLC, doing business as Prevention Genetics, has established itself as a trusted provider of genetic...

This is a sole-source firm-fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Prevention Genetics LLC, a for-profit limited liability company, to provide specialized genetic testing services. The contract, valued at $60,000.00, is for the continuation of genetic analysis of the TNXB and CAH-X genes to support the NIH's ongoing Natural History Study of Patients with Excess Androgens, protocol #06-CH-0011. Prevention Genetics is the only CLIA-certified...

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory based in Fort Myers, Florida. The $24,614 contract is for the provision of human genomics testing services to support the diagnosis and assessment of hematological disorders and malignancies for the NHLBI's Hematology Branch/Wiestner...

This contract is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration to Personal Genome Diagnostics Inc., a for-profit company that specializes in genomic and molecular diagnostic testing services. Under the contract, Personal Genome Diagnostics will provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network hospitals with a cancer diagnosis. This includes targeted DNA sequencing, whole exome sequencing, and RNA...

This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...

The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Myriad Genetics Inc. for $154,938.00 to provide Prolaris genetic testing services. Prolaris is a molecular diagnostic test that measures gene expression levels to assess prostate cancer aggressiveness. This contract is for the VA Long Beach Healthcare System to utilize Myriad's Prolaris testing capabilities on an as-needed basis from...

This federal contract award is for medical laboratory testing services and was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a leading provider of genetic testing and diagnostic services. The contract, valued at $81,410.00, is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market. Genedx operates from its facilities in Maryland and has held several Indefinite Delivery Vehicle (IDV) contracts with the...

This federal contract award, with an ID of 75N90018K00052, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The $82,281.25 firm fixed-price purchase order is for medical laboratory testing services, primarily to support research and clinical programs at the NIH. Genedx, a wholly-owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic services to the federal government. This...